Sex-based cardiac physiology

Annual Review of Physiology

Volumn 71, Issue , 2009, Pages 1-18

  Luczak, Elizabeth D ^a   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Estrogen; Gender; Phytoestrogen; Testosterone

Indexed keywords

ADRENERGIC RECEPTOR; ANTIESTROGEN; ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM ION; CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; DAIDZEIN; DNA; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR RECEPTOR; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOESTROGEN; PROTEIN KINASE B; RELAXIN; RESVERATROL; RYANODINE RECEPTOR; SEX HORMONE; TESTOSTERONE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ADRENERGIC SYSTEM; AGING; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DIASTOLE; DIETARY INTAKE; DISEASE COURSE; DISEASE MODEL; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; EXERCISE; FEMALE; GENE MUTATION; HEART; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; REVIEW; SEX DIFFERENCE; SOYBEAN; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; SYSTOLE; TREATMENT OUTCOME; WOMEN'S HEALTH;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MICE; PHYTOESTROGENS; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 67651165572     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.010908.163156     Document Type: Review

References (132)

1. de Simone G, Devereux RB, Daniels SR, Meyer RA. 1995. Gender differences in left ventricular growth. Hypertension 26:979-983
2. Zak R. 1974. Development and proliferative capacity of cardiac muscle cells. Circ. Res. 35(Suppl. II):17-26
3. Grandi AM, Venco A, Barzizza F, Scalise F, Pantaleo P, Finardi G. 1992. Influence of age and sex on left ventricular anatomy and function in normals. Cardiology 81:8-13
4. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, et al. 1995. Gender differences and aging: effects on the human heart. J. Am. Coll. Cardiol. 26:1068-1079
5. Sullivan MJ, Cobb FR, Higginbotham MB. 1991. Stroke volume increases by similar mechanisms during upright exercise in normal men and women. Am. J. Cardiol. 67:1405-1412
6. Higginbotham MB, Morris KG, Coleman RE, Cobb FR. 1984. Sex-related differences in the normal cardiac response to upright exercise. Circulation 70:357-366
7. De Maria R, Gavazzi A, Recalcati F, Baroldi G, De Vita C, Camerini F. 1993. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am. J. Cardiol. 72:580-585
8. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH. 1998. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J. Am. Coll. Cardiol. 32:1118-1125
9. Deswal A, Bozkurt B. 2006. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am. J. Cardiol. 97:1228-1231
10. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. 1992. Prevalence and mortality rate of congestive heart failure in the United States. J. Am. Coll. Cardiol. 20:301-306
11. Hofman A, Grobbee DE, de Jong PT, Van Den Ouweland FA. 1991. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 7:403-422
12. Martin CA, Thompson PL, Armstrong BK, Hobbs MS, de Klerk N. 1983. Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register. Circulation 68:961-969
13. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. 1999. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med. 341:217-225
14. Ni H. 2003. Prevalence of self-reported heart failure among US adults: results from the 1999 National Health Interview Survey. Am. Heart J. 146:121-128 (Pubitemid 36851310)
15. Lindenfeld J, Krause-Steinrauf H, Salerno J. 1997. Where are all the women with heart failure? J. Am. Coll. Cardiol. 30:1417-1419 (Pubitemid 27486455)
16. Wenger NK. 1992. Exclusion of the elderly and women from coronary trials. Is their quality of care compromised? JAMA 268:1460-1461
17. Hayward CS, Kalnins WV, Kelly RP. 2001. Gender-related differences in left ventricular chamber function. Cardiovasc. Res. 49:340-350 (Pubitemid 32119551)
18. Gurwitz JH, Col NF, Avorn J. 1992. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268:1417-1422
19. Mohan SB, Parker M, Wehbi M, Douglass P. 2002. Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Clevel. Clin. J. Med. 69:481-487 (Pubitemid 34678942)
20. Fernandez-Sola J, Nicolas-Arfelis JM. 2002. Gender differences in alcoholic cardiomyopathy. J. Gend. Specif. Med. 5:41-47
21. Schaible TF, Penpargkul S, Scheuer J. 1981. Cardiac responses to exercise training in male and female rats. J. Appl. Physiol. 50:112-117
22. Schaible TF, Scheuer J. 1979. Effects of physical training by running or swimming on ventricular performance of rat hearts. J. Appl. Physiol. 46:854-860 (Pubitemid 9181109)
23. Schaible TF, Scheuer J. 1981. Cardiac function in hypertrophied hearts from chronically exercised female rats. J. Appl. Physiol. 50:1140-1145 (Pubitemid 11078925)
24. Mole PA. 1978. Increased contractile potential of papillary muscles from exercise-trained rat hearts. Am. J. Physiol. 234:H421-25
25. Konhilas JP, Maass AH, Luckey SW, Stauffer BL, Olson EN, Leinwand LA. 2004. Sex modifies exercise and cardiac adaptation in mice. Am. J. Physiol. Heart Circ. Physiol. 287:H2768-76
26. Giuberti K, Pereira RB, Bianchi PR, Paigel AS, Vassallo DV, Stefanon I. 2007. Influence of ovariectomy in the right ventricular contractility in heart failure rats. Arch. Med. Res. 38:170-175 (Pubitemid 46080547)
27. Smith PJ, Ornatsky O, Stewart DJ, Picard P, Dawood F, et al. 2000. Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation 102:2983-2989
28. Cavasin MA, Tao Z, Menon S, Yang XP. 2004. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci. 75:2181-2192 (Pubitemid 39127470)
29. Jain M, Liao R, Podesser BK, Ngoy S, Apstein CS, Eberli FR. 2002. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 283:H2544-50 (Pubitemid 35345961)
30. Podesser BK, Jain M, Ngoy S, Apstein CS, Eberli FR. 2007. Unveiling gender differences in demand ischemia: a study in a rat model of genetic hypertension. Eur. J. Cardiothorac. Surg. 31:298-304 (Pubitemid 46157272)
31. Gerdes AM, Onodera T, Wang X, McCune SA. 1996. Myocyte remodeling during the progression to failure in rats with hypertension. Hypertension 28:609-614 (Pubitemid 26327957)
32. McCune SA, Park S, Radin MJ, Jurin RR. 1996. Renal and heart function in the SHHF/Mcc-cp rat. In Mechanisms of Heart Failure, ed. PK Singal, IMC Dixon, RE Beamish, NS Dhalla, MA Norwell, pp. 91-106. Dordrecht, Neth.: Kluwer Acad.
33. Tamura T, Said S, Gerdes AM. 1999. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 33:676-680 (Pubitemid 29091646)
34. McCune SA, Baker PB, Stills HFJ. 1990. SHHF/Mcc-cp rat: model of obesity, noninsulin-dependent diabetes, and congestive heart failure. ILAR News 32:23-27
35. Stauffer BL, Konhilas JP, Luczak ED, Leinwand LA. 2006. Soy diet worsens heart disease in mice. J. Clin. Investig. 116:209-216
36. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, et al. 1990. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 62:999-1006 (Pubitemid 20269146)
37. Vikstrom KL, Factor SM, Leinwand LA. 1996. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol. Med. 2:556-567
38. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, Mendelsohn ME. 1997. Electrophysiological abnormalities and arrhythmias in α MHC mutant familial hypertrophic cardiomyopathy mice. J. Clin. Investig. 99:570-576 (Pubitemid 27097655)
39. Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA. 2004. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation 110:2102-2109
40. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, et al. 1999. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J. Clin. Investig. 104:469-481 (Pubitemid 29534331)
41. Tardiff JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, et al. 1998. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Investig. 101:2800-2811
42. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323:236-241 (Pubitemid 20225044)
43. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, et al. 1995. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:1479-1486
44. Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, et al. 1996. Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int. J. Cardiol. 54:217-225 (Pubitemid 26226634)
45. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, et al. 1996. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711 (Pubitemid 26052456)
46. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, et al. 1997. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ. Res. 81:627-635
47. Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM. 2000. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J. Clin. Investig. 106:589-597 (Pubitemid 30666392)
48. Rockman HA, Koch WJ, Lefkowitz RJ. 2002. Seven-transmembrane-spanning receptors and heart function. Nature 415:206-212
49. Gao XM, Agrotis A, Autelitano DJ, Percy E, Woodcock EA, et al. 2003. Sex hormones and cardiomyopathic phenotype induced by cardiac β2-adrenergic receptor overexpression. Endocrinology 144:4097-4105 (Pubitemid 37088765)
50. 1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Investig. 111:1783-1791
51. Dash R, Kadambi V, Schmidt AG, Tepe NM, Biniakiewicz D, et al. 2001. Interactions between phospholamban and β-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103:889-896 (Pubitemid 32163890)
52. Dash R, Schmidt AG, Pathak A, Gerst MJ, Biniakiewicz D, et al. 2003. Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy. Cardiovasc. Res. 57:704-714 (Pubitemid 36254864)
53. Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, et al. 2001. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J. Biol. Chem. 276:24145-24152 (Pubitemid 37410820)
54. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, et al. 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice. J. Clin. Investig. 102:1083-1091 (Pubitemid 28436268)
55. Nohammer C, Brunner F, Wolkart G, Staber PB, Steyrer E, et al. 2003. Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor α knockout mice overexpressing lipoprotein lipase in muscle. Lab. Investig. 83:259-269 (Pubitemid 36255370)
56. Bryant-Greenwood GD, Schwabe C. 1994. Human relaxins: chemistry and biology. Endocr. Rev. 15:5-26
57. Osheroff PL, Ho WH. 1993. Expression of relaxin mRNA and relaxin receptors in postnatal and adult rat brains and hearts. Localization and developmental patterns. J. Biol. Chem. 268:15193-15199 (Pubitemid 23206674)
58. Kakouris H, Eddie LW, Summers RJ. 1992. Cardiac effects of relaxin in rats. Lancet 339:1076-1078
59. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ, Tregear GW. 2003. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc. Res. 57:395-404 (Pubitemid 36144218)
60. Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, et al. 2002. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 99:907-912 (Pubitemid 34106609)
61. Luckey SW, Mansoori J, Fair K, Antos CL, Olson EN, Leinwand LA. 2007. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am. J. Physiol. Heart Circ. Physiol. 292:H838-45
62. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. 1998. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256-261
63. Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, et al. 2004. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 110:3270-3275 (Pubitemid 39525076)
64. Schaible TF, Malhotra A, Ciambrone G, Scheuer J. 1984. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ. Res. 54:38-49 (Pubitemid 14196446)
65. Levin ER. 2001. Cell localization, physiology, and nongenomic actions of estrogen receptors. J. Appl. Physiol. 91:1860-1867
66. Mahmoodzadeh S, Eder S, Nordmeyer J, Ehler E, Huber O, et al. 2006. Estrogen receptor α upregulation and redistribution in human heart failure. FASEB J. 20:926-934 (Pubitemid 44943950)
67. Greenspan FS, Gardner DG. 2004. Basic & Clinical Endocrinology. New York: Lange Medical Books/McGraw-Hill. 976 pp.
68. Hewitt SC, Harrell JC, Korach KS. 2005. Lessons in estrogen biology from knockout and transgenic animals. Annu. Rev. Physiol. 67:285-308
69. Couse JF, Korach KS. 1999. Estrogen receptor null mice: What have we learned and where will they lead us? Endocr. Rev. 20:358-417
70. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. 2005. Estrogen receptor β mediates gender differences in ischemia/reperfusion injury. J. Mol. Cell Cardiol. 38:289-297 (Pubitemid 40215198)
71. Zhai P, Eurell TE, Cooke PS, Lubahn DB, Gross DR. 2000. Myocardial ischemia-reperfusion injury in estrogen receptor-α knockout and wild-type mice. Am. J. Physiol. Heart Circ. Physiol. 278:H1640-47 (Pubitemid 30395577)
72. Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, et al. 2005. Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 288:H469-76 (Pubitemid 40139627)
73. Pelzer T, Loza PA, Hu K, Bayer B, Dienesch C, et al. 2005. Increased mortality and aggravation of heart failure in estrogen receptor-β knockout mice after myocardial infarction. Circulation 111:1492-1498 (Pubitemid 40470643)
74. Brower GL, Gardner JD, Janicki JS. 2003. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol. Cell Biochem. 251:89-95
75. Bhuiyan MS, Shioda N, Fukunaga K. 2007. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Am. J. Physiol. Endocrinol. Metab. 293:E1606-14 (Pubitemid 350255110)
76. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 2001. 17β-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419-1423 (Pubitemid 32880156)
77. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. 1993. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107-115 (Pubitemid 23195439)
78. Harman SM. 2006. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend. Med. 3:254-269
79. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from theWomen's Health Initiative randomized controlled trial. JAMA 288:321-333 (Pubitemid 34761611)
80. Vickers MR, Maclennan AH, Lawton B, Ford D, Martin J, et al. 2007. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. Br. Med. J. 335:239 (Pubitemid 47262422)
81. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, et al. 1996. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335:453-461 (Pubitemid 26269944)
82. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, et al. 1999. 17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc. Res. 43:666-674 (Pubitemid 29369265)
83. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U. 1998. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31:582-588 (Pubitemid 28086940)
84. Johnson BD, Zheng W, Korach KS, Scheuer T, CatterallWA, Rubanyi GM. 1997. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J. Gen. Physiol. 110:135-140 (Pubitemid 27340485)
85. Chu SH, Goldspink P, Kowalski J, Beck J, Schwertz DW. 2006. Effect of estrogen on calcium-handling proteins, β-adrenergic receptors, and function in rat heart. Life Sci. 79:1257-1267 (Pubitemid 44188794)
86. 2+ in guinea-pig isolated cardiac myocytes. Br. J. Pharmacol. 106:739-745
87. 2+ exchange in the heart from ovariectomized rats: role of protein kinase A. Am. J. Physiol. Cell Physiol. 292:C1625-35
88. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, et al. 2004. 17β-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ. Res. 95:692-699 (Pubitemid 39331929)
89. Shiraishi I, Melendez J, Ahn Y, Skavdahl M, Murphy E, et al. 2004. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ. Res. 94:884-891 (Pubitemid 38490065)
90. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KDR, et al. 2001. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res. 88:1020-1027 (Pubitemid 34137114)
91. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. 2003. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 284:H1560-69 (Pubitemid 36460767)
92. Sluijmer AV, Heineman MJ, De Jong FH, Evers JL. 1995. Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. J. Clin. Endocrinol. Metab. 80:2163-2167
93. Sachtleben TR, Berg KE, Elias BA, Cheatham JP, Felix GL, Hofschire PJ. 1993. The effects of anabolic steroids on myocardial structure and cardiovascular fitness. Med. Sci. Sports Exerc. 25:1240-1245
94. Urhausen A, Holpes R, Kindermann W. 1989. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur. J. Appl. Physiol. Occup. Physiol. 58:633-640 (Pubitemid 19111884)
95. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. 1998. The cardiac toxicity of anabolic steroids. Prog. Cardiovasc. Dis. 41:1-15
96. Fisher CR, Graves KH, Parlow AF, Simpson ER. 1998. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. USA 95:6965-6970
97. Head GA, Obeyesekere VR, Jones ME, Simpson ER, Krozowski ZS. 2004. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity. Endocrinology 145:4286-4291
98. Setchell KD, Brown NM, Lydeking-Olsen E. 2002. The clinical importance of the metabolite equol: a clue to the effectiveness of soy and its isoflavones. J. Nutr. 132:3577-3584 (Pubitemid 35435031)
99. Safford B, Dickens A, Halleron N, Briggs D, Carthew P, Baker V. 2003. A model to estimate the oestrogen receptor mediated effects from exposure to soy isoflavones in food. Regul. Toxicol. Pharmacol. 38:196-209 (Pubitemid 37194526)
100. Fujimoto N, Honda H, Kitamura S. 2004. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors α and β. J. Steroid Biochem. Mol. Biol. 88:53-59 (Pubitemid 38326597)
101. Toda K, Hayashi Y, Okada T, Morohashi K, Saibara T. 2005. Expression of the estrogen-inducible EGFP gene in aromatase-null mice reveals differential tissue responses to estrogenic compounds. Mol. Cell. Endocrinol. 229:119-126 (Pubitemid 40018090)
102. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, et al. 2002. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277:22896-22901 (Pubitemid 34967272)
103. Kumi-Diaka J, Sanderson NA, Hall A. 2000. The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biol. Cell 92:595-604 (Pubitemid 32366627)
104. Yoon HS, Moon SC, Kim ND, Park BS, Jeong MH, Yoo YH. 2000. Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem. Biophys. Res. Commun. 276:151-156
105. Yellayi S, Naaz A, Szewczykowski MA, Sato T, Woods JA, et al. 2002. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc. Natl. Acad. Sci. USA 99:7616-7621 (Pubitemid 34568740)
106. Penza M, Montani C, Romani A, Vignolini P, Pampaloni B, et al. 2006. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147:5740-5751 (Pubitemid 44833490)
107. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. 2006. The Connectivity Map: using geneexpression signatures to connect small molecules, genes, and disease. Science 313:1929-1935 (Pubitemid 44497995)
108. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. 2006. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113:1034-1044 (Pubitemid 43879479)
109. Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S. 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based ( JPHC) study cohort I. Circulation 116:2553-2562 (Pubitemid 350179220)
110. Glover A, Assinder SJ. 2006. Acute exposure of adult male rats to dietary phytoestrogens reduces fecundity and alters epididymal steroid hormone receptor expression. J. Endocrinol. 189:565-573 (Pubitemid 43922122)
111. Jefferson WN, Padilla-Banks E, Newbold RR. 2005. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol. Reprod. 73:798-806 (Pubitemid 41356140)
112. Adams NR. 1995. Detection of the effects of phytoestrogens on sheep and cattle. J. Anim. Sci. 73:1509-1515
113. Leopold AS, Erwin M, Oh J, Browning B. 1976. Phytoestrogens: adverse effects on reproduction in California quail. Science 191:98-100
114. Setchell KD, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, et al. 1987. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93:225-233
115. Brown NM, Setchell KD. 2001. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab. Investig. 81:735-747
116. Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, et al. 1999. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab. Anim. Sci. 49:530-536 (Pubitemid 29508445)
117. Adlercreutz H, Markkanen H, Watanabe S. 1993. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209-1210 (Pubitemid 23331713)
118. King RA, Bursill DB. 1998. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 67:867-872
119. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, et al. 1998. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J. Nutr. 128:1710-1715 (Pubitemid 28452856)
120. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125:2307-2315
121. Djuric Z, Chen G, Doerge DR, Heilbrun LK, Kucuk O. 2001. Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett. 172:1-6 (Pubitemid 32823466)
122. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. 1997. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350:23-27 (Pubitemid 27279766)
123. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196 (Pubitemid 37150899)
124. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. 2006. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16:296-300 (Pubitemid 43190229)
125. Baur JA, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5:493-506
126. Fremont L. 2000. Biological effects of resveratrol. Life Sci. 66:663-673
127. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. 2000. Resveratrol acts as a mixed agonist/ antagonist for estrogen receptors α and β. Endocrinology 141:3657-3667
128. Klinge CM, Risinger KE, Watts MB, Beck V, Eder R, Jungbauer A. 2003. Estrogenic activity in white and red wine extracts. J. Agric. Food Chem. 51:1850-1857
129. Juric D, Wojciechowski P, Das DK, Netticadan T. 2007. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am. J. Physiol. Heart Circ. Physiol. 292:H2138-43 (Pubitemid 47084592)
130. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK. 2005. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul. Pharmacol. 42:281-289 (Pubitemid 40726331)
131. Liew R, Stagg MA, MacLeod KT, Collins P. 2005. The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur. J. Pharmacol. 519:1-8 (Pubitemid 43181157)
132. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. 1999. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med. 27:160-169 (Pubitemid 29353096)